Zheng, Luqing – Trademark Portfolio

Entity Type: 01

Zheng, Luqing holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include DUOCHIC, DUOCATCH, DUOCHARM, and DUOCHEER. The owner is based in Zibo.

2-3-1401,Yinling International,No. 79

Huaguang Road, Zhangdian Dist

Zibo 255022 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DUOCHEER
DUOCHEER
Registered 2021
DUOCHIC
DUOCHIC
Registered 2021
DUOCHARM
DUOCHARM
Registered 2021
DUOCATCH
DUOCATCH
Registered 2021

Trademark Classifications

Zheng, Luqing's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (3 filings)

Clothing, footwear, headgear

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Zheng, Luqing have?

Zheng, Luqing has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Zheng, Luqing file in?

Zheng, Luqing files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 9 (Computers & Electronics). Class 25 covers clothing, footwear, headgear.

What are Zheng, Luqing's most well-known trademarks?

Zheng, Luqing's registered trademark portfolio includes well-known marks such as DUOCHIC, DUOCATCH, DUOCHARM, and DUOCHEER. These are among 4 currently registered trademarks in the portfolio.

What is Zheng, Luqing's trademark registration success rate?

Zheng, Luqing has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.